I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Callahan, Margaret K
848
results:
Search for persons
X
Format
Online (848)
Mediatypes
E-Books (2)
Articles (Online) (735)
Bookchapter (Online) (18)
OpenAccess-fulltext (93)
Sorted by: Relevance
Sorted by: Year
?
1
Durable complete response in a patient with leptomeningeal ..:
Lochrin, Sarah E.
;
Buonocore, Darren J.
;
Young, Robert J.
...
Pigment Cell & Melanoma Research. , 2024
Link:
https://doi.org/10.1111/..
?
2
A topic modeling approach reveals the dynamic T cell compos..:
Peng, Xiyu
;
Lee, Jasme
;
Adamow, Matthew
...
Cell Reports Methods. 3 (2023) 8 - p. 100546 , 2023
Link:
https://doi.org/10.1016/..
?
3
Integration of peripheral blood‐ and tissue‐based biomarker..:
Vanguri, Rami S
;
Smithy, James W
;
Li, Yanyun
...
The Journal of Pathology. 261 (2023) 3 - p. 349-360 , 2023
Link:
https://doi.org/10.1002/..
?
4
Phase Ib Trial of Phenformin in Patients with V600-mutated ..:
Chapman, Paul B.
;
Klang, Mark
;
Postow, Michael A.
...
Cancer Research Communications. 3 (2023) 12 - p. 2447-2454 , 2023
Link:
https://doi.org/10.1158/..
?
5
Beyond the 5‐year milestone: Long‐term survivorship of mela..:
Loo, Kimberly
;
Kalvin, Hannah L.
;
Panageas, Katherine S.
...
Pigment Cell & Melanoma Research. 36 (2023) 3-4 - p. 314-320 , 2023
Link:
https://doi.org/10.1111/..
?
6
Decision-Making and Health-Related Quality of Life in Patie..:
Atkinson, Thomas M
;
Hay, Jennifer L
;
Young Kim, Soo
...
The Oncologist. 28 (2023) 4 - p. 351-357 , 2023
Link:
https://doi.org/10.1093/..
?
7
Author Correction: Fundamental immune–oncogenicity trade-of..:
Hoyos, David
;
Zappasodi, Roberta
;
Schulze, Isabell
...
Nature. 606 (2022) 7914 - p. E5-E5 , 2022
Link:
https://doi.org/10.1038/..
?
8
Tumor MHC Class I Expression Associates with Intralesional ..:
Pourmaleki, Maryam
;
Jones, Caitlin J.
;
Ariyan, Charlotte E.
...
Cancer Immunology Research. 10 (2022) 3 - p. 303-313 , 2022
Link:
https://doi.org/10.1158/..
?
9
Fundamental immune–oncogenicity trade-offs define driver mu..:
Hoyos, David
;
Zappasodi, Roberta
;
Schulze, Isabell
...
Nature. 606 (2022) 7912 - p. 172-179 , 2022
Link:
https://doi.org/10.1038/..
?
10
First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist ..:
Yap, Timothy A.
;
Gainor, Justin F.
;
Callahan, Margaret K.
...
Clinical Cancer Research. 28 (2022) 17 - p. 3695-3708 , 2022
Link:
https://doi.org/10.1158/..
?
11
Safety, tolerability and efficacy of agonist anti-CD27 anti..:
Sanborn, Rachel E
;
Pishvaian, Michael J
;
Callahan, Margaret K
...
Journal for ImmunoTherapy of Cancer. 10 (2022) 8 - p. e005147 , 2022
Link:
https://doi.org/10.1136/..
?
12
Inherited PD-1 deficiency underlies tuberculosis and autoim..:
Ogishi, Masato
;
Yang, Rui
;
Aytekin, Caner
...
Nature Medicine. 27 (2021) 9 - p. 1646-1654 , 2021
Link:
https://doi.org/10.1038/..
?
13
Clinical implications of drug‐induced liver injury in early..:
Mondaca, Sebastian P.
;
Liu, Dazhi
;
Flynn, Jessica R.
...
Cancer. 126 (2020) 22 - p. 4967-4974 , 2020
Link:
https://doi.org/10.1002/..
?
14
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recu..:
Ready, Neal E.
;
Ott, Patrick A.
;
Hellmann, Matthew D.
...
Journal of Thoracic Oncology. 15 (2020) 3 - p. 426-435 , 2020
Link:
https://doi.org/10.1016/..
?
15
Defining tumor resistance to PD-1 pathway blockade: recomme..:
Kluger, Harriet M.
;
Tawbi, Hussein A.
;
Ascierto, Maria L.
...
Journal for ImmunoTherapy of Cancer. 8 (2020) 1 - p. e000398 , 2020
Link:
https://doi.org/10.1136/..
1-15